12:00 AM
May 17, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Cotara (131I-chTNT-1/B): Began Phase I/II testing

Techniclone Corp. (TCLN), Tustin, Calif.
Product: Cotara ( 131I-chTNT-1/B)
Business: Cancer
Therapeutic category: Cytotoxic,...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >